Health
Anti-infective therapy for infections caused by drug-resistant gram-negative pathogens now in Phase I study – Outbreak News Today – Outbreak News Today
By NewsDesk @infectiousdiseasenews Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase…
By NewsDesk @infectiousdiseasenews
Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase 1 study of QPX9003, a next generation intravenous (IV)-administered synthetic polymyxin for infections caused by drug-resistant…
Continue Reading
-
Noosa News21 hours agoBrisbane’s original 1979 electric trains take one last journey
-
General4 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General20 hours agoParis opens River Seine for public swimming for first time since 1923
-
Noosa News13 hours agoRainbow Beach surfer’s untold 7/7 story